Ólavur Mortensen carefully loaded the final DNA sample into the sequencer at the FarGen laboratory in Tórshavn, the quiet capital of the Faroe Islands, where the North Atlantic wind howls through narrow valleys like the one in Gásadalur pictured in a now-iconic photograph. What emerged from that machine—and 39 other whole genomes—was a genetic portrait of a people shaped by isolation, survival, and a bottleneck so profound it surpasses even that of the Finnish population. In a groundbreaking study published in eLife, researchers Iman Hamid, Ólavur Mortensen, and Alba Refoyo-Martínez unveiled the first large-scale whole-genome analysis of Faroese individuals, revealing how evolutionary forces have sculpted one of Europe’s most unique populations.
The Faroe Islands, perched between Iceland and Norway, were likely first settled around the 9th century by Norse and Gaelic seafarers, though evidence hints at earlier habitation. For centuries, the population remained small and isolated, creating the perfect conditions for a genetic bottleneck—a sharp reduction in diversity that leaves lasting marks in the genome. The study found that Faroese individuals carry more of their genome in long runs of homozygosity (ROH) than nearly any other European group, including the Finnish, a population long studied for its founder effects. These long ROHs indicate recent shared ancestry, pointing to a population that once hovered near the edge of genetic survival.
But the story isn’t just about loss—it’s also about adaptation. The team identified genes under positive selection, including POLQ, involved in DNA repair and linked to cancer resilience, and SLC10A1, which enhances vitamin D absorption. This last gene may have been crucial for survival in the Faroes’ dim northern latitudes, where sunlight is scarce for much of the year. Another surprise was the elevated genetic diversity in the lactase persistence gene, suggesting a dietary shift from marine fats to dairy—a change that may have begun only centuries ago but left a measurable imprint on the genome.
The implications extend beyond history. With high rates of type 2 diabetes and multiple sclerosis in the population, understanding the Faroese genome could unlock clues to disease susceptibility and resilience. Because the genomes were sequenced locally at the FarGen lab, the study also marks a milestone in regional scientific autonomy. As researchers continue to explore this genetic legacy, the Faroe Islands stand not just as a remote archipelago, but as a living laboratory of human evolution—where the past is written in every strand of DNA.
Now, as genomic medicine advances, the Faroese may offer insights that ripple far beyond their shores, turning isolation into illumination.